Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EMPhosphatidylinositol-3-kinase (pi3k) inhibitors
- Chemical substanceL01EM01Idelalisib
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 2 registrations
Spain
AEMPS · 2 registrations
Netherlands
CBG-MEB · 2 registrations
At a glance
- ATC code
- L01EM01
- Registers
- 7
- Registrations
- 11
- With their own page
- 10
- Companies
- 6
All medicines with Idelalisib
Human medicines from every register that match Idelalisib by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
11 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Idelalisib | United States | 100MG, 150MG | tablet | Marketed | Natco |
| Zydelig | United States | 100MG, 150MG | tablet | Marketed | Gilead Sciences INC |
| Zydelig | European Union | Authorised | Gilead Sciences Ireland UC | ||
| Zydelig 100 mg comprimidos recubiertos con pelicula | Spain | 100 mg | comprimido recubierto con película | Marketed | Gilead Sciences Ireland Unlimited Company |
| Zydelig 150 mg comprimidos recubiertos con pelicula | Spain | 150 mg | comprimido recubierto con película | Marketed | Gilead Sciences Ireland Unlimited Company |
| Zydelig 100 mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| Zydelig 150 mg, filmomhulde tablet | Netherlands | Filmomhulde tablet | Authorised | Gilead Sciences Ireland UC | |
| Zydelig | Canada | 150 MG | Tablet | Marketed | Gilead Sciences Canada INC |
| Zydelig | Canada | 100 MG | Tablet | Marketed | Gilead Sciences Canada INC |
| Zydelig | Croatia | Marketed | |||
| ZYDELIG Tablets 100MG | Taiwan | 膜衣錠 | Cancelled | 香港商吉立亞醫藥有限公司台灣分公司 |